ID

31466

Description

ADenosine Following Pulmonary Vein Isolation to Target Dormant Conduction Elimination: the ADVICE Trial; ODM derived from: https://clinicaltrials.gov/show/NCT01058980

Link

https://clinicaltrials.gov/show/NCT01058980

Keywords

Versions (1)
  1. 8/25/18 8/25/18 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

August 25, 2018

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Paroxysmal Atrial Fibrillation NCT01058980

English

Eligibility Paroxysmal Atrial Fibrillation NCT01058980

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
age more than 18 years
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
paroxysmal af for at least 6 months with at least 3 symptomatic episodes (using patient history) during the previous 6 months
Description

Paroxysmal atrial fibrillation Disease length | Episode Symptomatic Quantity

Data type

boolean

Alias
UMLS CUI [1,1]
C0235480
UMLS CUI [1,2]
C0872146
UMLS CUI [2,1]
C0332189
UMLS CUI [2,2]
C0231220
UMLS CUI [2,3]
C1265611
patients must be felt to be candidates for af ablation based on af that is symptomatic and refractory or intolerant to at least one class 1 or 3 antiarrhythmic agent.
Description

Patients Appropriate Ablation Atrial Fibrillation | ATRIAL FIBRILLATION SYMPTOMATIC | Atrial Fibrillation Unresponsive to Treatment | Intolerance to Anti-Arrhythmia Agents Class Quantity

Data type

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C1548787
UMLS CUI [1,3]
C0547070
UMLS CUI [1,4]
C0004238
UMLS CUI [2]
C0741283
UMLS CUI [3,1]
C0004238
UMLS CUI [3,2]
C0205269
UMLS CUI [4,1]
C1744706
UMLS CUI [4,2]
C0003195
UMLS CUI [4,3]
C0456387
UMLS CUI [4,4]
C1265611
documentation of at least one episode of af on 12 lead ecg, ttm or holter monitor within 12 months of randomization in the trial
Description

Atrial Fibrillation Episode Quantity 12 lead ECG | Other Coding | Atrial Fibrillation Episode Quantity Holter Electrocardiography

Data type

boolean

Alias
UMLS CUI [1,1]
C0004238
UMLS CUI [1,2]
C0332189
UMLS CUI [1,3]
C1265611
UMLS CUI [1,4]
C0430456
UMLS CUI [2]
C3846158
UMLS CUI [3,1]
C0004238
UMLS CUI [3,2]
C0332189
UMLS CUI [3,3]
C1265611
UMLS CUI [3,4]
C0013801
patients must be on continuous anticoagulation with warfarin (inr 2-3) or fractionated subcutaneous heparin for >4 weeks prior to the ablation or they have undergone a recent (less than 48 hours before planned ablation) transoesophageal echocardiogram to exclude left atrial thrombus.
Description

Anticoagulation Therapy | Warfarin | International Normalized Ratio | Subcutaneous heparin Fractionated | Transesophageal Echocardiography Excludes Thrombus of left atrium

Data type

boolean

Alias
UMLS CUI [1]
C0003281
UMLS CUI [2]
C0043031
UMLS CUI [3]
C0525032
UMLS CUI [4,1]
C0353681
UMLS CUI [4,2]
C1979893
UMLS CUI [5,1]
C0206054
UMLS CUI [5,2]
C0332196
UMLS CUI [5,3]
C3532827
patients must provide written informed consent to participate in the clinical trial.
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
contraindications to oral anticoagulants
Description

Medical contraindication Oral anticoagulants

Data type

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0354604
history of any previous ablation or surgical maze for af
Description

Ablation Atrial Fibrillation In the past | Surgical Maze Procedure In the past

Data type

boolean

Alias
UMLS CUI [1,1]
C0547070
UMLS CUI [1,2]
C0004238
UMLS CUI [1,3]
C1444637
UMLS CUI [2,1]
C3272262
UMLS CUI [2,2]
C1444637
intracardiac thrombus
Description

Intracardiac thrombus

Data type

boolean

Alias
UMLS CUI [1]
C0876998
af due to reversible cause
Description

Atrial Fibrillation Due to Cause Reversible

Data type

boolean

Alias
UMLS CUI [1,1]
C0004238
UMLS CUI [1,2]
C0678226
UMLS CUI [1,3]
C0015127
UMLS CUI [1,4]
C0205343
patients with left atrial size > 55mm or significant mitral valve disease (moderate or severe mitral stenosis or regurgitation)
Description

Left atrium Size | Diseases of mitral valve | MITRAL STENOSIS MODERATE | Mitral Valve Stenosis Severe | Mitral regurgitation Moderate | Mitral regurgitation Severe

Data type

boolean

Alias
UMLS CUI [1,1]
C0225860
UMLS CUI [1,2]
C0456389
UMLS CUI [2]
C0026265
UMLS CUI [3]
C0746601
UMLS CUI [4,1]
C0026269
UMLS CUI [4,2]
C0205082
UMLS CUI [5,1]
C0026266
UMLS CUI [5,2]
C0205081
UMLS CUI [6,1]
C0026266
UMLS CUI [6,2]
C0205082
pregnancy
Description

Pregnancy

Data type

boolean

Alias
UMLS CUI [1]
C0032961
asthma, history of bronchospasm or known adverse reaction to adenosine
Description

Asthma | Bronchial Spasm | Adverse reactions Adenosine

Data type

boolean

Alias
UMLS CUI [1]
C0004096
UMLS CUI [2]
C0006266
UMLS CUI [3,1]
C0559546
UMLS CUI [3,2]
C0001443
Back to the top of the page

Similar models

Eligibility Paroxysmal Atrial Fibrillation NCT01058980

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
age more than 18 years
boolean
C0001779 (UMLS CUI [1])
Paroxysmal atrial fibrillation Disease length | Episode Symptomatic Quantity
Item
paroxysmal af for at least 6 months with at least 3 symptomatic episodes (using patient history) during the previous 6 months
boolean
C0235480 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
C0332189 (UMLS CUI [2,1])
C0231220 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
Patients Appropriate Ablation Atrial Fibrillation | ATRIAL FIBRILLATION SYMPTOMATIC | Atrial Fibrillation Unresponsive to Treatment | Intolerance to Anti-Arrhythmia Agents Class Quantity
Item
patients must be felt to be candidates for af ablation based on af that is symptomatic and refractory or intolerant to at least one class 1 or 3 antiarrhythmic agent.
boolean
C0030705 (UMLS CUI [1,1])
C1548787 (UMLS CUI [1,2])
C0547070 (UMLS CUI [1,3])
C0004238 (UMLS CUI [1,4])
C0741283 (UMLS CUI [2])
C0004238 (UMLS CUI [3,1])
C0205269 (UMLS CUI [3,2])
C1744706 (UMLS CUI [4,1])
C0003195 (UMLS CUI [4,2])
C0456387 (UMLS CUI [4,3])
C1265611 (UMLS CUI [4,4])
Atrial Fibrillation Episode Quantity 12 lead ECG | Other Coding | Atrial Fibrillation Episode Quantity Holter Electrocardiography
Item
documentation of at least one episode of af on 12 lead ecg, ttm or holter monitor within 12 months of randomization in the trial
boolean
C0004238 (UMLS CUI [1,1])
C0332189 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C0430456 (UMLS CUI [1,4])
C3846158 (UMLS CUI [2])
C0004238 (UMLS CUI [3,1])
C0332189 (UMLS CUI [3,2])
C1265611 (UMLS CUI [3,3])
C0013801 (UMLS CUI [3,4])
Anticoagulation Therapy | Warfarin | International Normalized Ratio | Subcutaneous heparin Fractionated | Transesophageal Echocardiography Excludes Thrombus of left atrium
Item
patients must be on continuous anticoagulation with warfarin (inr 2-3) or fractionated subcutaneous heparin for >4 weeks prior to the ablation or they have undergone a recent (less than 48 hours before planned ablation) transoesophageal echocardiogram to exclude left atrial thrombus.
boolean
C0003281 (UMLS CUI [1])
C0043031 (UMLS CUI [2])
C0525032 (UMLS CUI [3])
C0353681 (UMLS CUI [4,1])
C1979893 (UMLS CUI [4,2])
C0206054 (UMLS CUI [5,1])
C0332196 (UMLS CUI [5,2])
C3532827 (UMLS CUI [5,3])
Informed Consent
Item
patients must provide written informed consent to participate in the clinical trial.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Medical contraindication Oral anticoagulants
Item
contraindications to oral anticoagulants
boolean
C1301624 (UMLS CUI [1,1])
C0354604 (UMLS CUI [1,2])
Ablation Atrial Fibrillation In the past | Surgical Maze Procedure In the past
Item
history of any previous ablation or surgical maze for af
boolean
C0547070 (UMLS CUI [1,1])
C0004238 (UMLS CUI [1,2])
C1444637 (UMLS CUI [1,3])
C3272262 (UMLS CUI [2,1])
C1444637 (UMLS CUI [2,2])
Intracardiac thrombus
Item
intracardiac thrombus
boolean
C0876998 (UMLS CUI [1])
Atrial Fibrillation Due to Cause Reversible
Item
af due to reversible cause
boolean
C0004238 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C0015127 (UMLS CUI [1,3])
C0205343 (UMLS CUI [1,4])
Left atrium Size | Diseases of mitral valve | MITRAL STENOSIS MODERATE | Mitral Valve Stenosis Severe | Mitral regurgitation Moderate | Mitral regurgitation Severe
Item
patients with left atrial size > 55mm or significant mitral valve disease (moderate or severe mitral stenosis or regurgitation)
boolean
C0225860 (UMLS CUI [1,1])
C0456389 (UMLS CUI [1,2])
C0026265 (UMLS CUI [2])
C0746601 (UMLS CUI [3])
C0026269 (UMLS CUI [4,1])
C0205082 (UMLS CUI [4,2])
C0026266 (UMLS CUI [5,1])
C0205081 (UMLS CUI [5,2])
C0026266 (UMLS CUI [6,1])
C0205082 (UMLS CUI [6,2])
Pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])
Asthma | Bronchial Spasm | Adverse reactions Adenosine
Item
asthma, history of bronchospasm or known adverse reaction to adenosine
boolean
C0004096 (UMLS CUI [1])
C0006266 (UMLS CUI [2])
C0559546 (UMLS CUI [3,1])
C0001443 (UMLS CUI [3,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial